CARDIOPROGRESS
Foundation for the advancement of cardiology

Quadpill Strategy Gains Ground in Hypertension Several new antihypertensive agents are reshaping the therapeutic strategies for patients with uncontrolled or resistant hypertension. Agents such as baxdrostat, the first selective aldosterone synthase inhibitor, and aprocitentan, a dual endothelin receptor A and B antagonist, are paving the way for new drug combinations and a more personalized approach to blood pressure control.

Heart Risks Rise, Care Lags: New Stats Expose Harsh Truths Researchers compiled a national data report on the burden, quality of care, and mortality trends for major cardiovascular risk factors and conditions in the US.

Updated recommendations for adults with congenital heart defects On December 18, updated guidelines for management of adults with congenital heart disease, developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) in conjunction with several other societies, were published in Circulation and the Journal of the American College of Cardiology.

Can Interventional EP Go Outpatient? Is interventional electrophysiology poised for a paradigm shift? The American College of Cardiology and Heart Rhythm Society may think so. In a joint scientific statement, they offer guidance on performing certain procedures, such as cardiac ablation, in facilities that provide same-day surgical care without the need for hospital admission.

New Pediatric CPR Guidelines: Key Updates for Clinicians More than 7,000 community-acquired cardiac arrests occur in the United States each year. New methods are aimed at restoring breathing, clearing clogged airways and improving survival.

Upcoming Joint Guidelines to Address Obesity Management Upcoming evidence-based clinical guidelines from three obesity organizations will address US-based pharmacologic management of overweight/obesity and its complications in adults.

Resistant hypertension: a new look Modern management of patients with arterial hypertension requires a consistent approach to treatment and prevention, with particular attention paid to the problem of low adherence to treatment. Lifestyle optimization and elimination of secondary hypertension causes are identified as key strategies.

Results of the 36th International Congress of Cardiology "Great Wall" and the Asian Congress of Cardiology 2025 The 36th International Congress of Cardiology “Great Wall” and the Asian Congress of Cardiology 2025 took place at the National Exhibition Center in Beijing from October 16 to 19, 2025.

New guidelines may help prevent sudden death in myocarditis The European Society of Cardiology (ESC) recently released its 2025 guidelines for the management of myocarditis, which also includes extensive discussion of pericarditis and the wide range of overlap between these types of cardiac inflammation. The guidelines were presented at the ESC Congress 2025 in Madrid and simultaneously published in the European Heart Journal.

Nobel Prize in Physiology or Medicine 2025 The Nobel Prize in Physiology or Medicine 2025 was awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi "for their discoveries concerning peripheral immune tolerance.